Evidence map›Paper›PMID 40686193›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025

Molten-Salt-Mediated Synthesis of Atomic Manganese/Cobalt Catalysts on Bioceramic Microparticles for Catalytic Anti-Osteoarthritis Treatments.

Ronghui Deng, Zining Zhang, Aijun Wu, Chaoqin Shu, Shitang Song, Fuzhen Yuan, Zijie Xu, Meng Yang, Jing Ye, Yifan Song and 2 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ronghui DengSports Medicine Department, Beijing Key Laboratory of Sports Injuries, Peking University Third Hospital, Beijing, 100191, P. R. China.ORCID https://orcid.org/0000-0003-1282-8289
Zining ZhangSports Medicine Department, Beijing Key Laboratory of Sports Injuries, Peking University Third Hospital, Beijing, 100191, P. R. China.
Aijun WuState Key Laboratory of High Performance Ceramics and Superfine Microstructure, Shanghai Institute of Ceramics, Chinese Academy of Sciences, Shanghai, 200050, P. R. China.
Chaoqin ShuState Key Laboratory of High Performance Ceramics and Superfine Microstructure, Shanghai Institute of Ceramics, Chinese Academy of Sciences, Shanghai, 200050, P. R. China.
Shitang SongSports Medicine Department, Beijing Key Laboratory of Sports Injuries, Peking University Third Hospital, Beijing, 100191, P. R. China.
Fuzhen YuanSports Medicine Department, Beijing Key Laboratory of Sports Injuries, Peking University Third Hospital, Beijing, 100191, P. R. China.
Zijie XuSports Medicine Department, Beijing Key Laboratory of Sports Injuries, Peking University Third Hospital, Beijing, 100191, P. R. China.
Meng YangSports Medicine Department, Beijing Key Laboratory of Sports Injuries, Peking University Third Hospital, Beijing, 100191, P. R. China.
Jing YeSports Medicine Department, Beijing Key Laboratory of Sports Injuries, Peking University Third Hospital, Beijing, 100191, P. R. China.
Yifan SongSports Medicine Department, Beijing Key Laboratory of Sports Injuries, Peking University Third Hospital, Beijing, 100191, P. R. China.
Yufang ZhuState Key Laboratory of High Performance Ceramics and Superfine Microstructure, Shanghai Institute of Ceramics, Chinese Academy of Sciences, Shanghai, 200050, P. R. China.
Jia-Kuo YuSports Medicine Department, Beijing Key Laboratory of Sports Injuries, Peking University Third Hospital, Beijing, 100191, P. R. China.ORCID https://orcid.org/0000-0001-6260-7017

Funding

National Key Research and Development Program of China 2021YFB3800800National Natural Science Foundation of China 32271393National Natural Science Foundation of China 51920105006Space Application System of China Manned Space Program KJZ-YY-NCL05
6 · The paper itself

Abstract

Osteoarthritis (OA) is a chronic progressive joint disease characterized by cartilage degeneration and local inflammation, and its progression is closely related to the excessive production of reactive oxygen species (ROS). Despite progress made with small molecule antioxidants and nanozymes, effective antioxidant therapy for the long-term elimination of these ROS remains challenging, largely due to the rapid clearance of antioxidants from the joints via synovial vessels and lymphatics. Herein, a molten-salt method is developed to facilitate the atomic dispersion of Mn or Co ions homogeneously on the surface of akermanite microparticles (AKT-MPs). The micrometer-scale Mn- or Co-AKT-MPs with multi-mimetic enzyme effects are demonstrated to obliterate multiple ROS, thereby protecting the inherent homeostasis between chondrocyte anabolism and catabolism, while suppressing the conversion of macrophages to a pro-inflammatory phenotype. In addition, the microparticles exhibited chondroprotection of ROS-challenged cartilage explants in vitro by limiting the loss of cartilage extracellular matrix (ECM) and the release of degradative enzymes. Furthermore, Mn- or Co-AKT-MPs are injected intra-articularly into monosodium iodoacetate (MIA)-induced OA mice and effectively suppress synovial inflammation, painful symptoms, and progression of early cartilage destruction. Therefore, this microparticle-based antioxidant therapy provides an insight and paradigm to control atomic catalysts integrated with microparticles for efficient catalytic anti-OA treatments.

Indexed as

AntioxidantsCeramicsCobaltManganeseOsteoarthritisAnimalsCartilage, ArticularCatalysisChondrocytesDisease Models, AnimalExtracellular MatrixInjections, Intra-ArticularIodoacetic AcidMaleMiceMice, Inbred BALB CAntioxidantsCobaltGlass ceramicsIodoacetic AcidManganeseReactive Oxygen Speciesantioxidantbioceramicmicroparticlesmolten‐salt methodosteoarthritis

Identifiers

PMID40686193
PMCPMC12376603

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.